Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.
Giorgi Rossi P, Lebeau A, Canelo-Aybar C, Saz-Parkinson Z, Quinn C, Langendam M, Mcgarrigle H, Warman S, Rigau D, Alonso-Coello P, Broeders M, Graewingholt A, Posso M, Duffy S, Schünemann HJ; ECIBC Contributor Group. Giorgi Rossi P, et al. Br J Cancer. 2021 Apr;124(9):1503-1512. doi: 10.1038/s41416-020-01247-z. Epub 2021 Feb 18. Br J Cancer. 2021. PMID: 33597715 Free PMC article. Review.
Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer.
Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, Castro C, Rapiti E, Katalinic A, Torrella A, Žagar T, Bielska-Lasota M, Giorgi Rossi P, Larrañaga N, Bastos J, Sánchez MJ, Sant M; European HR Working Group on breast cancer. Minicozzi P, et al. Among authors: giorgi rossi p. Int J Cancer. 2019 May 1;144(9):2118-2127. doi: 10.1002/ijc.31974. Epub 2018 Dec 27. Int J Cancer. 2019. PMID: 30411340 Free article.
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer.
Giorgi Rossi P, Lebeau A, Schünemann HJ; Multigene Test PICO (Population, Intervention, Comparison, Outcome) Responsible Unit of the Guidelines Development Group, European Commission Initiative on Breast Cancer. Giorgi Rossi P, et al. N Engl J Med. 2019 Sep 26;381(13):1289-1290. doi: 10.1056/NEJMc1909693. N Engl J Med. 2019. PMID: 31553845 No abstract available.
Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
Muratov S, Canelo-Aybar C, Tarride JE, Alonso-Coello P, Dimitrova N, Borisch B, Castells X, Duffy SW, Fitzpatrick P, Follmann M, Giordano L, Hofvind S, Lebeau A, Quinn C, Torresin A, Vialli C, Siesling S, Ponti A, Giorgi Rossi P, Schünemann H, Nyström L, Broeders M; ECIBC contributor group. Muratov S, et al. Among authors: giorgi rossi p. BMC Cancer. 2020 Aug 24;20(1):795. doi: 10.1186/s12885-020-07289-z. BMC Cancer. 2020. PMID: 32831048 Free PMC article.
Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes.
Piggott T, Langendam M, Parmelli E, Adolfsson J, Akl EA, Armstrong D, Braithwaite J, Brignardello-Petersen R, Brozek J, Gore-Booth J, Follmann M, Leś Z, Meerpohl JJ, Neamţiu L, Nothacker M, Qaseem A, Giorgi Rossi P, Saz-Parkinson Z, van der Wees P, Schünemann HJ. Piggott T, et al. Among authors: giorgi rossi p. BMC Health Serv Res. 2021 Feb 24;21(1):172. doi: 10.1186/s12913-020-05819-w. BMC Health Serv Res. 2021. PMID: 33627104 Free PMC article.
Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Canelo-Aybar C, Carrera L, Beltrán J, Posso M, Rigau D, Lebeau A, Gräwingholt A, Castells X, Langendam M, Pérez E, Giorgi Rossi P, Van Engen R, Parmelli E, Saz-Parkinson Z, Alonso-Coello P. Canelo-Aybar C, et al. Among authors: giorgi rossi p. Cancer Med. 2021 Apr;10(7):2191-2204. doi: 10.1002/cam4.3803. Epub 2021 Mar 5. Cancer Med. 2021. PMID: 33675147 Free PMC article.
Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Canelo-Aybar C, Posso M, Montero N, Solà I, Saz-Parkinson Z, Duffy SW, Follmann M, Gräwingholt A, Giorgi Rossi P, Alonso-Coello P. Canelo-Aybar C, et al. Among authors: giorgi rossi p. Br J Cancer. 2022 Mar;126(4):673-688. doi: 10.1038/s41416-021-01521-8. Epub 2021 Nov 26. Br J Cancer. 2022. PMID: 34837076 Free PMC article.
A Randomized Trial Comparing Breast Cancer Incidence and Interval Cancers after Tomosynthesis Plus Mammography versus Mammography Alone.
Pattacini P, Nitrosi A, Giorgi Rossi P, Duffy SW, Iotti V, Ginocchi V, Ravaioli S, Vacondio R, Mancuso P, Ragazzi M, Campari C; RETomo Working Group. Pattacini P, et al. Among authors: giorgi rossi p. Radiology. 2022 May;303(2):256-266. doi: 10.1148/radiol.211132. Epub 2022 Feb 1. Radiology. 2022. PMID: 35103537 Clinical Trial.
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trial.
Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Giorgi Rossi P, Balleyguier C, Guindy M, Gilbert FJ, Burrion JB, Castells X, Ritchie D, Keatley D, Baron C, Delaloge S, de Montgolfier S. Roux A, et al. Among authors: giorgi rossi p. BMC Cancer. 2022 May 6;22(1):507. doi: 10.1186/s12885-022-09484-6. BMC Cancer. 2022. PMID: 35524202 Free PMC article.
409 results